University of Medicine and Dentistry of New Jersey
Also known as: Child and Adolescent Psychiatry, UMDNJ | Department of Emergency Medicine, UMDNJ - Robert Wood Johnson Medical School | Division of Child and Adolescent Psychiatry at the University of Medicine and Dentistry of New Jersey | Obstetrics, Gynecology, and Women's Health, University of Medicine and Dentistry of New Jersey | Robert Wood Johnson Medical School, New Brunswick, NJ, USA | Robert Wood Johnson Medical School, UMDNJ, New Brunswick, NJ | Stuart D Cook MD | T. George Hornby | UMDNJ, Department of Medicine | UMDNJ - New Jersey Medical School | UMDNJ - NJ Medical School | UMDNJ-NJMS | UMDNJ/NJMS | UMDNJ-Robert Wood Johnson Medical School at Camden, Cooper University Hospital, Camden, New Jersey | UMDNJ - Robert Wood Johnson Medical School, Camden, NJ | UMDNJ - Robert Wood Johnson Medical School, Division of Endocrinology | UMDNJ - Robert Wood Johnson University Hospital | UMDNJ - RWJMS | UMDNJ-RWJMS | UMDNJ/SOM | UMDNJ University Hospital / St Joseph Medical Center | University Medicine & Dentistry of NJ | University of Medicine and Dentistry of New Jersey | University of Medicine and Dentistry of New Jersey, Cancer Institute of New Jersey | University of Medicine and Dentistry of New Jersey/ New Jersey Medical School | University of Medicine and Dentistry of New Jersey, NJMS-UH/UMDNJ Cancer Center, and University Heights Advanced Imaging Center, Newark, NJ | University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine | University of Medicine & Dentistry of New Jersey | University of Medicine & Dentistry of NJ, Robert Wood Johnson Medical School | University of Medicne & Dentistry of New Jersey
Highest phase reached
Phase 4
First clinical trial
Dec 1, 1971Last known activity
Jan 1, 2014
Timeline
1950s
- Jan 1, 1954
University of Medicine and Dentistry of New Jersey— Founded
Drugs by trial phase (125 distinct, 96 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (19 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (19 own, 0 via acquisition)
Other trials (22 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anemia
- Anxiety Disorders
- Autistic Disorder
- Blast Crisis
- Bone Diseases, Metabolic
- Bone Marrow Diseases
- Borderline Personality Disorder
- Brain Stem Infarctions
- Breast Neoplasms
- Burkitt Lymphoma
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Colorectal Neoplasms
- Congenital Abnormalities
- Depression
- Dermatitis
- Dermatitis, Atopic
- Disease
- Dyspnea
- Eczema
- Emergence Delirium
- End Stage Liver Disease
- Fatigue
- Fatigue Syndrome, Chronic
- Fibromyalgia
- Gallbladder Diseases
- Head and Neck Neoplasms
- Heart Diseases
- Heart Failure
- Hematologic Diseases
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hernia
- HIV Infections
- Hodgkin Disease
- Hyperglycemia
- Hypoxia
- Immunoblastic Lymphadenopathy
- Infarction
- Infections
- Inflammatory Breast Neoplasms
- Influenza, Human
- Intraocular Lymphoma
- Kidney Neoplasms
- Klippel-Trenaunay-Weber Syndrome
- Leukemia
- Leukemia, Hairy Cell
- Leukemia, Large Granular Lymphocytic
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia-Lymphoma, Adult T-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Accelerated Phase
- Leukemia, Myeloid, Acute
- Leukemia, T-Cell
- Liver Diseases
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
- Lymphoma, T-Cell, Peripheral
- Lymphomatoid Granulomatosis
- Lymphoproliferative Disorders
- Melanoma
- Metaplasia
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Myalgia
- Mycoses
- Mycosis Fungoides
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Myocardial Infarction
- Myofascial Pain Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Neoplasms, Unknown Primary
- Osteoporosis
Recent trials (50)
- NCT01652014Lead sponsorPhase 2Jan 1, 2014
- NCT01938040Lead sponsorPhase 4May 1, 2013
- NCT01711073Overall official - principal investigatorPhase 1Oct 1, 2012
- NCT01711073CollaboratorPhase 1Oct 1, 2012
- NCT01742338Lead sponsorPhase 4May 1, 2012
- NCT01533376CollaboratorPhase 1Feb 1, 2012
- NCT01538693Lead sponsorN/ADec 1, 2011
- NCT01538693CollaboratorN/ADec 1, 2011
- NCT01611038Lead sponsorN/AOct 1, 2011
- NCT01510119CollaboratorPhase 1/Phase 2Sep 1, 2011
- NCT01641653Overall official - principal investigatorPhase 4Jun 1, 2011
- NCT01641653Lead sponsorPhase 4Jun 1, 2011
- NCT01657643Overall official - principal investigatorN/AJan 1, 2011
- NCT01657643Lead sponsorN/AJan 1, 2011
- NCT01308736Overall official - principal investigatorN/AJan 1, 2011
Details
- Founded
- Newark, US Jan 1, 1954
- Last known activity
- Jan 1, 2014